Katkin Keith
SEC insider (Form 3/4/5 filer). CIK 0001314596. Director at Emergent BioSolutions Inc. (EBS) and 2 other issuers. 10 reported Form 4/5 transactions since Sep 2024; latest on Apr 30, 2026. Located in NEW YORK, NY.
Companies Katkin Keith has filed insider reports for
- Emergent BioSolutions Inc. (EBS): Director
- Syndax Pharmaceuticals Inc (SNDX): Director
- Eledon Pharmaceuticals, Inc. (ELDN): Director
Katkin Keith
CIK: 0001314596
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Apr 30, 2026EBS
Emergent BioSolutions Inc.
AwardDirect25.3K shares- - Apr 30, 2026EBS
Emergent BioSolutions Inc.
SaleDirect15.5K shares at avg. $8.28$128K - Feb 4, 2026SNDX
Syndax Pharmaceuticals Inc
AwardDirect24K shares- - Jan 10, 2026ELDN
Eledon Pharmaceuticals, Inc.
ExerciseDirect8.6K shares- - May 23, 2025EBS
Emergent BioSolutions Inc.
SaleDirect7.8K shares at avg. $6.30$49K - May 19, 2025SNDX
Syndax Pharmaceuticals Inc
PurchaseDirect10K shares at avg. $9.11$91K - Apr 30, 2025EBS
Emergent BioSolutions Inc.
AwardDirect34.4K shares- - Feb 5, 2025SNDX
Syndax Pharmaceuticals Inc
AwardDirect25K shares- - Jan 10, 2025ELDN
Eledon Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
77.2K shares- - Jan 10, 2025ELDN
Eledon Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
8.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 30, 2026 |  EBS Emergent BioSolutions Inc. | Award | 25,344 | - | $0 | Direct |
| Apr 30, 2026 | EBS Emergent BioSolutions Inc. | Sale | 15,481 | $8.28 | $128,183 | Direct |
| Feb 4, 2026 |  SNDX Syndax Pharmaceuticals Inc | Award | 24,000 | - | $0 | Direct |
| Jan 10, 2026 |  ELDN Eledon Pharmaceuticals, Inc. | Exercise | 8,575 | - | $0 | Direct |
| May 23, 2025 | EBS Emergent BioSolutions Inc. | Sale | 7,844 | $6.30 | $49,417 | Direct |
| May 19, 2025 | SNDX Syndax Pharmaceuticals Inc | Purchase | 10,000 | $9.11 | $91,120 | Direct |
| Apr 30, 2025 | EBS Emergent BioSolutions Inc. | Award | 34,403 | - | - | Direct |
| Feb 5, 2025 | SNDX Syndax Pharmaceuticals Inc | Award | 25,000 | - | - | Direct |
| Jan 10, 2025 | ELDN Eledon Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 77,175 | - | - | Direct |
| Jan 10, 2025 | ELDN Eledon Pharmaceuticals, Inc. | Award Restricted Stock Units | 8,575 | - | - | Direct |
1-10 of 10 transactions